{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T21:18:53Z","timestamp":1780089533011,"version":"3.54.0"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,9]]},"abstract":"<jats:sec>\n            <jats:title>Purpose of review<\/jats:title>\n            <jats:p>To investigate the association between systemic sclerosis (SSc) to chronic hepatitis B virus (HBV) and hepatitis C virus (HCV) carriage. We utilized the database of Clalit Health Services, the largest healthcare organization in Israel and performed a cross-sectional study.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Recent findings<\/jats:title>\n            <jats:p>The study included 2431 SSc patients and 12\u200a710 age-and-sex matched controls, HBV was found in 38 SSc patients (1.56%) and 64 controls (0.5%). HCV was found in 30 SSc patients (1.23%) and 83 controls (0.65%). In multivariable logistic regression model, HBV was found to be associated with smoking, dialysis treatment and SSc [odds ratio (OR) 2.97, 95% confidence interval (CI) 1.92\u20134.53]. HCV was found to be associated with dialysis treatment and SSc (OR 1.73, 95% CI 1.1\u20132.66). A trend was found between both HBV and HCV toward low socioeconomic status. SSc patients with HBV had demonstrated higher rates of end-stage renal disease requiring dialysis treatment.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Summary<\/jats:title>\n            <jats:p>In our study, HBV and HCV were found to be associated with SSc. Common immune mechanisms or therapeutic modalities may serve as mediators of this association.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/bor.0000000000000623","type":"journal-article","created":{"date-parts":[[2019,7,29]],"date-time":"2019-07-29T13:43:46Z","timestamp":1564407826000},"page":"493-498","source":"Crossref","is-referenced-by-count":9,"title":["The association between hepatitis B, hepatitis C and systemic sclerosis: a cross-sectional study"],"prefix":"10.1097","volume":"31","author":[{"given":"Shmuel","family":"Tiosano","sequence":"first","affiliation":[{"name":"Department of Medicine \u2018B\u2019"},{"name":"Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Tel-Hashomer"},{"name":"Sackler Faculty of Medicine, Tel-Aviv University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnon D.","family":"Cohen","sequence":"additional","affiliation":[{"name":"Department of Quality Measurements and Research, Clalit Health Services, Tel Aviv"},{"name":"Siaal Research Center for Family Medicine and Primary Care, Faculty of Health Sciences, Ben Gurion University of the Negev, Beer Sheva, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Howard","family":"Amital","sequence":"additional","affiliation":[{"name":"Department of Medicine \u2018B\u2019"},{"name":"Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Tel-Hashomer"},{"name":"Sackler Faculty of Medicine, Tel-Aviv University"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230829","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1136\/ard.2008.088989","article-title":"The \u2212670G\u200a>\u200aA polymorphism in the FAS gene promoter region influences the susceptibility to systemic sclerosis","volume":"68","author":"Liakouli","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"R2-20230829","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jdermsci.2010.06.008","article-title":"The impact of Fli1 deficiency on the pathogenesis of systemic sclerosis","volume":"59","author":"Asano","year":"2010","journal-title":"J Dermatol Sci"},{"key":"R3-20230829","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1002\/art.24600","article-title":"Association of a functional polymorphism in the IRF5 region with systemic sclerosis in a Japanese population","volume":"60","author":"Ito","year":"2009","journal-title":"Arthritis Rheum"},{"key":"R4-20230829","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/s10067-016-3533-1","article-title":"Occupational and environmental scleroderma. Systematic review and meta-analysis","volume":"36","author":"Rubio-Rivas","year":"2017","journal-title":"Clin Rheumatol"},{"key":"R5-20230829","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.autrev.2010.09.010","article-title":"Do infections facilitate the emergence of systemic sclerosis?","volume":"10","author":"Grossman","year":"2011","journal-title":"Autoimmun Rev"},{"key":"R6-20230829","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1111\/j.1749-6632.2009.04808.x","article-title":"The role of infections in the immunopathogensis of systemic sclerosis-evidence from serological studies","volume":"1173","author":"Arnson","year":"2009","journal-title":"Ann N Y Acad Sci"},{"key":"R7-20230829","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s12016-007-8013-6","article-title":"Hepatitis B virus (HBV) and autoimmune disease","volume":"34","author":"Maya","year":"2008","journal-title":"Clin Rev Allergy Immunol"},{"key":"R8-20230829","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1016\/S1590-8658(07)80005-3","article-title":"HCV-related autoimmune and neoplastic disorders: the HCV syndrome","volume":"39","author":"Ferri","year":"2007","journal-title":"Dig Liver Dis"},{"key":"R9-20230829","first-page":"404","article-title":"Prevalence of selected chronic diseases in Israel","volume":"3","author":"Rennert","year":"2001","journal-title":"Isr Med Assoc J"},{"key":"R10-20230829","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s12026-016-8886-7","article-title":"Chronic hepatitis C viral infection among SLE patients: the significance of coexistence","volume":"65","author":"Mahroum","year":"2017","journal-title":"Immunol Res"},{"key":"R11-20230829","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1002\/clc.22927","article-title":"Pericarditis among giant cell arteritis patients: from myth to reality","volume":"41","author":"Tiosano","year":"2018","journal-title":"Clin Cardiol"},{"key":"R12-20230829","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.clim.2018.12.012","article-title":"The long-term prognostic significance of sarcoidosis-associated pulmonary hypertension: a cohort study","volume":"199","author":"Tiosano","year":"2019","journal-title":"Clin Immunol Orlando Fla"},{"key":"R14-20230829","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.autrev.2008.07.012","article-title":"HBV and HCV chronic infection: autoimmune manifestations and lymphoproliferation","volume":"8","author":"Zignego","year":"2008","journal-title":"Autoimmun Rev"},{"key":"R15-20230829","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s00281-012-0328-6","article-title":"Autoimmune manifestations in viral hepatitis","volume":"35","author":"Vergani","year":"2013","journal-title":"Semin Immunopathol"},{"key":"R16-20230829","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1007\/s00296-009-1009-1","article-title":"Discoid lupus erythematosus in a patient with scleroderma and hepatitis C virus infection","volume":"30","author":"Yamamoto","year":"2010","journal-title":"Rheumatol Int"},{"key":"R17-20230829","first-page":"625","article-title":"Systemic sclerosis developing in association with the use of interferon alpha therapy for chronic viral hepatitis","volume":"22","author":"Solans","year":"2004","journal-title":"Clin Exp Rheumatol"},{"key":"R18-20230829","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1007\/s100670070031","article-title":"Systemic sclerosis: another rheumatic disease associated with hepatitis C virus infection","volume":"19","author":"Abu-Shakra","year":"2000","journal-title":"Clin Rheumatol"},{"key":"R19-20230829","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/978-3-319-98477-3_10","article-title":"Infections, cellulitis, and osteomyelitis","author":"Bellando-Randone","year":"2019","journal-title":"Atlas of Ulcers in Systemic Sclerosis"},{"key":"R20-20230829","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/acr.20673","article-title":"Scleroderma digital ulcers complicated by infection with fecal pathogens","volume":"64","author":"Giuggioli","year":"2012","journal-title":"Arthritis Care Res"},{"key":"R21-20230829","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1093\/qjmed\/91.5.375a","article-title":"Hepatitis E virus and systemic sclerosis","volume":"91","author":"Ferri","year":"1998","journal-title":"QJM"},{"key":"R22-20230829","first-page":"309","article-title":"Hepatic manifestations of autoimmune rheumatic diseases","volume":"18","author":"Soultati","year":"2005","journal-title":"Ann Gastroenterol"},{"key":"R23-20230829","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/MD.0000000000000018","article-title":"Early- versus late-onset systemic sclerosis: differences in clinical presentation and outcome in 1037 patients","volume":"93","author":"Alba","year":"2014","journal-title":"Medicine (Baltimore)"},{"key":"R24-20230829","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1002\/art.30071","article-title":"Cigarette smoking in patients with systemic sclerosis","volume":"63","author":"Hudson","year":"2011","journal-title":"Arthritis Rheum"},{"key":"R25-20230829","doi-asserted-by":"crossref","DOI":"10.1002\/acr.23861","article-title":"Increased morbidity and mortality of scleroderma in African Americans compared to Non-African Americans","author":"Moore","year":"2019","journal-title":"Arthritis Care Res"},{"key":"R26-20230829","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1111\/jvh.13060","article-title":"Awareness of chronic viral hepatitis in the United States: an update from the National Health and Nutrition Examination Survey","volume":"26","author":"Kim","year":"2019","journal-title":"J Viral Hepat"}],"container-title":["Current Opinion in Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/BOR.0000000000000623","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,29]],"date-time":"2023-08-29T07:06:44Z","timestamp":1693292804000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/BOR.0000000000000623"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":25,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/bor.0000000000000623","relation":{},"ISSN":["1040-8711","1531-6963"],"issn-type":[{"value":"1040-8711","type":"print"},{"value":"1531-6963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9]]}}}